Magnolol as a Radiotherapy Enhancer in Oral Squamous Cell Carcinoma: Targeting the EGFR/NF‐κB Pathway and Immune Modulation. The gene discussed is NFKB1; the disease is oral cavity squamous cell carcinoma.